Acta Med. 2009, 52: 9-13

https://doi.org/10.14712/18059694.2016.100

CC and CXC Chemokines Patterns in Psoriasis Determined by Protein Array Method Were Influenced by Goeckerman’s Therapy

David Pohla, Ctirad Andrýsa, Lenka Borskáb, Zdeněk Fialac, Květoslava Hamákovád, Karel Ettlerd, Jan Krejseka

aCharles University in Prague, Faculty of Medicine and University Hospital Hradec Králové, Department of Clinical Immunology and Allergy, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medicine and University Hospital Hradec Králové, Department of Pathological Physiology, Hradec Králové, Czech Republic
cCharles University in Prague, Faculty of Medicine and University Hospital Hradec Králové, Department of Hygiene and Preventive Medicine, Hradec Králové, Czech Republic
dCharles University in Prague, Faculty of Medicine and University Hospital Hradec Králové, Department of Dermatology and Venereology, Hradec Králové, Czech Republic

Received January 1, 2009
Accepted April 1, 2009

References

1. Adams DH, Lloyd AR. Chemokines: leucocyte recruitment and activation cytokines. Lancet 1997; 349:490–5. <https://doi.org/10.1016/S0140-6736(96)07524-1>
2. Albanesi C, Pastore S, Fanales-Belasio E, Girolomoni G. Cetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytes. Clin Exp Allergy 1998; 28:101–9. <https://doi.org/10.1046/j.1365-2222.1998.00206.x>
3. Andrys C, Borska L, Pohl D, Fiala Z, Hamakova K, Krejsek J. Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman’s therapy. Arch Dermatol Res 2007; 298:479–83. <https://doi.org/10.1007/s00403-006-0723-8>
4. Arakawa S, Hatano Y, Katagiri K, Terashi H, Fujiwara S. Effect of ultraviolet B irradiation on the production of regulated upon activation normal T-cell expressed and secreted protein in cultured human epidermal keratinocytes. Arch Dermatol Res 2006; 297: 377–80. <https://doi.org/10.1007/s00403-005-0620-6>
5. Arbiser JL, Govindarajan B, Battle TE, et al. Carbazole is a naturally occurring inhibitor of angiogenesis and inflammation isolated from antipsoriatic coal tar. J Invest Dermatol 2006; 126:1396–1402. <https://doi.org/10.1038/sj.jid.5700276>
6. Benoit S, Toksoy A, Brocker EB, Gillitzer R, Goebeler M. Treatment of recalcitrant psoriasis with infliximab: effective reduction of chemokine expression. Br J Dermatol 2004; 150:1009–12. <https://doi.org/10.1111/j.1365-2133.2004.05960.x>
7. Bhushan M, Young HS, Brenchley PEC, Griffiths CEM. Recent advances in cutaneous angiogenesis. Br J Dermatol 2002; 147:418–25. <https://doi.org/10.1046/j.1365-2133.2002.05003.x>
8. Creamer D, Sullivan D, Bicknell R, Barker J. Angiogenesis in psoriasis. Angiogenesis 2002; 5: 231–6. <https://doi.org/10.1023/A:1024515517623>
9. De Rie MA, Goedkoop AY, Bos JD. Overview of psoriasis. Dermatol Ther 2004; 17:341–9.
10. Folkman J. Angiogenesis. Annu Rev Med 2006; 57:1–18. <https://doi.org/10.1146/annurev.med.57.121304.131306>
11. Fukuoka M, Ogino Y, Sato H, et al. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Br J Dermatol 1998; 138:63–70. <https://doi.org/10.1046/j.1365-2133.1998.02027.x>
12. Gillitzer R, Ritter U, Spandau U, Goebeler M, Brocker EB. Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J Invest Dermatol 1996; 107:778–82. <https://doi.org/10.1111/1523-1747.ep12371803>
13. Gillitzer R, Wolff K, Tong D, et al. MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 1993; 101:127–31. <https://doi.org/10.1111/1523-1747.ep12363613>
14. Goeckerman WH. Treatment of psoriasis. Northwest Med 1925; 24:229–31.
15. Gudjonsson JE, Johnston A, Sigmundsdottir H, Valdimarsson H. Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 2004; 135:1–8. <https://doi.org/10.1111/j.1365-2249.2004.02310.x> <PubMed>
16. Huang RP. Detection of multiple proteins in an antibody-based protein microarray system. J Immunol Meth 2001; 255:1–13. <https://doi.org/10.1016/S0022-1759(01)00394-5>
17. Huang RP. Cytokine protein arrays. Meth Mol Biol 2004; 264:215–31.
18. Kojima T, Cromie MA, Fischer GJ, Voorhees JJ, Doder JT. GRO alpha mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporine A in vivo, but not in cultured keratinocytes. J Invest Dermatol 19932; 101:767–72. <https://doi.org/10.1111/1523-1747.ep12371692>
19. Kulke R, Bornscheuer E, Schluter C, et al. The CXC receptor 2 is overexpressed in psoriatic epidermis. J Invest Dermatol 1998; 110:90–4. <https://doi.org/10.1046/j.1523-1747.1998.00074.x>
20. Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol 2001; 45:487–98. <https://doi.org/10.1067/mjd.2001.117046>
21. Lee E, Koo J. Modern modified ‘ultra’ Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies. J DermatolTreat 2005; 16:102–7.
22. Leong TT, Fearon U, Veale DJ. Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis. Curr Rheumatol Rep 2005; 7:325–9. <https://doi.org/10.1007/s11926-005-0044-5>
23. Li J, Farthing PM, Thornhill MH. Oral and skin keratinocytes are stimulated to secrete monocyte chemoattractant protein-1 by tumour necrosis factor alpha and interferon gamma. J Oral Pathol Med 2000; 29:438–44. <https://doi.org/10.1034/j.1600-0714.2000.290904.x>
24. Li J, Ireland GW, Farthing PM, Thornhill MH. Epidermal and oral keratinocytes are induced to produce RANTES and IL-8 by cytokine stimulation. J Invest Dermatol 1996; 106: 661–6. <https://doi.org/10.1111/1523-1747.ep12345482>
25. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007; 445:866–73. <https://doi.org/10.1038/nature05663>
26. Nielsen HJ, Christensen IJ, Svendsen MN, et al. Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis. Inflamm Res 2002; 51:563–7. <https://doi.org/10.1007/PL00012428>
27. Raychaudhuri SP, Jiang WY, Farber EM, Schall TJ, Ruff MR, Pert CB. Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis. Acta Derm Venereol 1999; 79:9–11.
28. Steude J, Kulke R, Christophers E. Interleukin-1-stimulated secretion of interleukin- 8 and growth-related-oncogene-[alpha] demonstrates greatly enhanced keratinocyte growth in human raft cultured epidermis. J Invest Dermatol 2002; 119:1254–60. <https://doi.org/10.1046/j.1523-1747.2002.19616.x>
29. Streiter RM, Polverini PJ, Kunkel SL, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995; 270:27348–57. <https://doi.org/10.1074/jbc.270.45.27348>
30. Tille JC, Wood J, Mandriota SJ, et al. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF – and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro. J Pharmacol Exp Ther 2001; 299:1073–85.
31. Wang CC, Huang RP, Sommer M, et al. Array-based multiplexed screening and quantitation of human cytokines and chemokines. J Prot Res 2002; 1:337–43. <https://doi.org/10.1021/pr0255203>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive